Citalopram hydrobromide and Vertebral-basilar artery occlusive syndrome - from FDA reports


Summary

Vertebral-basilar artery occlusive syndrome is reported only by a few people who take Citalopram Hydrobromide. We study 23,116 people who have side effects while taking Citalopram hydrobromide from FDA. Among them, 1 have Vertebral-basilar artery occlusive syndrome. Find out below who they are, when they have Vertebral-basilar artery occlusive syndrome and more.

What to expect?

If you take Citalopram hydrobromide and have Vertebral-basilar artery occlusive syndrome, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Citalopram hydrobromide and have Vertebral-basilar artery occlusive syndrome

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Oct, 21, 2017

23,116 people reported to have side effects when taking Citalopram hydrobromide.
Among them, 1 person (0.0%) has Vertebral-basilar artery occlusive syndrome


Number of reports submitted per year:

Could Citalopram hydrobromide cause Vertebral-basilar artery occlusive syndrome?

Gender of people who have Vertebral-basilar artery occlusive syndrome when taking Citalopram hydrobromide *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Vertebral-basilar artery occlusive syndrome when taking Citalopram hydrobromide *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Top conditions involved for these people *:

  • Renal Failure Chronic (1 person, 100.00%)

Top co-used drugs for these people *:

  • Protonix (1 person, 100.00%)
  • Pantoprazole (1 person, 100.00%)
  • Furosemide (1 person, 100.00%)
  • Diovan (1 person, 100.00%)
  • Aspirin (1 person, 100.00%)

Top other side effects for these people *:

  • Subclavian Artery Stenosis (1 person, 100.00%)
  • Skin Ulcer (1 person, 100.00%)
  • Renal Failure Acute (1 person, 100.00%)
  • Impaired Healing (1 person, 100.00%)
  • Cardiac Failure Congestive (1 person, 100.00%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Vertebral-basilar artery occlusive syndrome when taking Citalopram hydrobromide?

Expand the study to include all drugs with the same ingredients

Vertebral-basilar artery occlusive syndrome and drugs with ingredients of citalopram hydrobromide.

Expand the study to include reports from both FDA and eHealthMe

Vertebral-basilar artery occlusive syndrome and Citalopram hydrobromide from FDA and eHealthMe reports

Citalopram hydrobromide

Citalopram hydrobromide has active ingredients of citalopram hydrobromide. It is often used in depression. (latest outcomes from Citalopram hydrobromide 26,765 users)

Vertebral-basilar artery occlusive syndrome

Vertebral-basilar artery occlusive syndrome (decrease of blood flow in the vertebral or basilar arteries due to atherosclerosis or compression placed on the external wall of the arteries) has been reported by people with osteoporosis, osteopenia, sleep disorder, spinal osteoarthritis, chronic obstructive pulmonary disease (latest reports from 87 Vertebral-basilar artery occlusive syndrome patients).

Browse all side effects of Citalopram hydrobromide

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Vertebral-basilar artery occlusive syndrome

Vertebral-basilar artery occlusive syndrome

Could your condition cause Vertebral-basilar artery occlusive syndrome

Vertebral-basilar artery occlusive syndrome

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Citalopram hydrobromide and have Vertebral-basilar artery occlusive syndrome.

Questions to the study

More questions >

User reviews to the study

More reviews >